De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes

Megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndromes are sporadic overgrowth disorders associated with markedly enlarged brain size and other recognizable features. We performed exome sequencing in 3 families with MCAP or MPPH, and...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 44; no. 8; pp. 934 - 940
Main Authors RIVIERE, Jean-Baptiste, MIRZAA, Ghayda M, WORTHYLAKE, Thea, SULLIVAN, Christopher T, WARD, Thomas R, BUTLER, Hailly E, KRAMER, Nancy A, ALBRECHT, Beate, ARMOUR, Christine M, ARMSTRONG, Linlea, CALUSERIU, Oana, CYTRYNBAUM, Cheryl, O'ROAK, Brian J, DROLET, Beth A, INNES, Amicheil, LAUZON, Juliel, LIN, Angela E, MANCINI, Grazia M. S, MESCHINO, Wendy S, REGGIN, James D, SAGGAR, Anand K, LERMAN-SAGIE, Tally, UYANIK, Gokhan, BEDDAOUI, Margaret, WEKSBERG, Rosanna, ZIRN, Birgit, BEAULIEU, Chandree L, MAJEWSKI, Jacek, BULMAN, Dennis E, O'DRISCOLL, Mark, SHENDURE, Jay, GRAHAM, John M, BOYCOTT, Kym M, DOBYNS, William B, ALCANTARA, Diana, CONWAY, Robert L, ST-ONGE, Judith, SCHWARTZENTRUBER, Jeremy A, GRIPP, Karen W, NIKKEL, Sarah M
Format Journal Article
LanguageEnglish
Published New York, NY Nature Publishing Group 01.08.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndromes are sporadic overgrowth disorders associated with markedly enlarged brain size and other recognizable features. We performed exome sequencing in 3 families with MCAP or MPPH, and our initial observations were confirmed in exomes from 7 individuals with MCAP and 174 control individuals, as well as in 40 additional subjects with megalencephaly, using a combination of Sanger sequencing, restriction enzyme assays and targeted deep sequencing. We identified de novo germline or postzygotic mutations in three core components of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. These include 2 mutations in AKT3, 1 recurrent mutation in PIK3R2 in 11 unrelated families with MPPH and 15 mostly postzygotic mutations in PIK3CA in 23 individuals with MCAP and 1 with MPPH. Our data highlight the central role of PI3K-AKT signaling in vascular, limb and brain development and emphasize the power of massively parallel sequencing in a challenging context of phenotypic and genetic heterogeneity combined with postzygotic mosaicism.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Membership of the Steering committee is provided in the Supplementary Note
ISSN:1061-4036
1546-1718
DOI:10.1038/ng.2331